Monthly Archives: March 2021

Best Gold Stocks To Watch For 2021

Concert of a Lifetime

“You’re crazy.”

Those were my wife’s words when I called her from the road, rushing to discuss what I termed “the concert of a lifetime.”

I’d just learned that living legends U2 were touring in support of the 30th anniversary of their most celebrated album, “The Joshua Tree.”  

(Photo by Andrew Chin/Getty Images)

The greatest live band of a generation playing the soundtrack of my youth from start to finish.

Andrea was on board with going to the show–she’s a big fan, too. But what invited her claim of insanity was my insistence that we take the whole family to Seattle to see the show. We live in Charleston. South Carolina.

Best Gold Stocks To Watch For 2021: Orezone Gold Corp (ORE)

Orezone Gold Corporation is a Canada-based company engaged in the exploration and development of gold properties in Burkina Faso, West Africa. The Company has two advanced-stage gold projects, which include Bombore and Bondi, which are located in Burkina Faso. The Company owns a 100% interest in Bombore, the undeveloped oxide gold deposit in West Africa. The Company’s Bombore is situated approximately 85 kilometers east of the capital city, Ouagadougou. The company’s Bondi gold project is a 100% owned, shallow and structurally controlled, four kilometers long shear zone hosted gold deposit that contains 282,000 ounce (oz) of measured and indicated gold resources. The Company’s Bondi Project is located on the Hounde Greenstone Belt in the southwest of Burkina Faso covering an area of approximately 168 square kilometers. Advisors’ Opinion:

  • [By Shane Hupp]

    Galactrum (ORE) is a PoW/PoS coin that uses the
    Lyra2RE hashing algorithm. It was first traded on December 13th, 2017. Galactrum’s total supply is 2,781,952 coins and its circulating supply is 2,061,952 coins. Galactrum’s official website is galactrum.org. Galactrum’s official Twitter account is @galactrum.

  • [By Stephan Byrd]

    Galactrum (CURRENCY:ORE) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 18:00 PM Eastern on August 31st. Galactrum has a total market capitalization of $866,847.00 and approximately $5,272.00 worth of Galactrum was traded on exchanges in the last 24 hours. One Galactrum coin can now be purchased for about $0.42 or 0.00006032 BTC on major exchanges including Stocks.Exchange and Cryptopia. In the last seven days, Galactrum has traded 12.5% higher against the U.S. dollar.

  • [By Peter Graham]

    Sandstorm’s due diligence is thorough, they don’t just invest in any company. They like West Africa because they understand the area and the opportunities that exist there. Sandstorm is a royalty and streaming company, so they make these investments and receive cashflow deals that often kick in much later on. But they have already established a presence in Burkina and have deals in place with larger companies like Orezone Gold (TSXV: ORE) and Endeavour Mining (TSX: EDV). Sandstorm’s investment also potentially gives us access to their marketing department through something they call Launch Lab, and it looks like it will really benefit our own marketing efforts and will expose us to more opportunities over the coming year.

  • [By Jim Robertson]

    Finally, Richard Seville, the CEO of Brisbane-based Orocobre Ltd (ASX: ORE) which began lithium sales in 2015 from northern Argentina and also experienced difficulty boosting output, commented that an “inability to access traditional funds has delayed the development of the sector” and that “these projects aren’t easy — so the banks just don’t want to go there.”

Best Gold Stocks To Watch For 2021: CME Group Inc.(CME)

CME Group Inc. operates the CME, CBOT, NYMEX, and COMEX regulatory exchanges worldwide. The company provides a range of products available across various asset classes, including futures and options on interest rates, equity indexes, energy, agricultural commodities, metals, foreign exchange, weather, and real estate. It offers various products that provide a means of hedging, speculation, and asset allocation relating to the risks associated with interest rate sensitive instruments, equity ownership, changes in the value of foreign currency, credit risk, and changes in the prices of commodities. CME Group owns and operates clearing house, CME Clearing, which provides clearing and settlement services for exchange-traded contracts and counter derivatives transactions; and also engages in real estate operations. Its primary trade execution facilities consist of its CME Globex electronic trading platform and open outcry trading floors, as well as privately negotiated transact ions that are cleared and settled through its clearing house. In addition, the company offers market data services comprising live quotes, delayed quotes, market reports, and historical data services, as well as involves in index services business. CME Group?s customer base includes professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, and governments. It has strategic partnerships with BM&FBOVESPA S.A., Bursa Malaysia Derivatives, Singapore Exchange Limited, Green Exchange, Dubai Mercantile Exchange, Johannesburg Stock Exchange, and Bolsa Mexicana de Valores, S.A.B. de C.V., as well as joint venture agreement with Dow Jones & Company. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group was founded in 1898 and is headquartered in Chicago, Illinois.

Advisors’ Opinion:

  • [By ]

    Sure, I will invest more in certain high-confidence picks than others, but without going overboard. This might limit the overall impact that a triple-digit winner makes in my High-Yield Investing portfolio — like the 156% gain we made on CME Group (Nasdaq: CME) when we sold in May 2018 — but it will also soften the blow from a laggard.

  • [By Logan Wallace]

    Berman Capital Advisors LLC acquired a new position in shares of CME Group Inc (NASDAQ:CME) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 276 shares of the financial services provider’s stock, valued at approximately $51,000.

  • [By Garrett Baldwin]

    Investors looking to make money on China should pay attention. While the United States is focusing this week on resolving issues with North Korea, the real elephant in the room remains China. President Trump has extended the artificial March 1 deadline on tariffs in hopes of striking a deal with the world’s second largest economy. However, it remains very unclear what will happen in the coming weeks. Investors should prepare themselves accordingly. Money Morning Quantitative Specialist Chris Johnson has scoured the numbers and given investors a number of ways to make money on this massive geopolitical trend, right here. We are seeing some problems on the trading front from CME Group Inc. (NYSE: CME). The Chicago-based exchange operator halted trading for three hours Tuesday night after a glitch caused an outage. GME Globex is a massive platform that enables the trading of stocks, interest rates, forex exchange (currencies), commodities, and other assets. Pay close attention to the headlines, as it’s still unclear if this was an internal issue or a cybersecurity event.
    Money Morning Insight of the Day

    According to Bloomberg’s latest report, America could be heading for an economic disaster that would rival the Great Recession.

  • [By Simon Erickson]

    The fourth quarter brought significant market volatility, as investors saw stock prices fall during the final few months of 2018. But CME Group (NASDAQ:CME), the operator of one of America’s largest options and derivatives exchanges, handsomely benefited. Trading volumes related to equity and interest-rate futures tend to spike during volatile times, which is why CME Group enjoyed a boost to its top and bottom lines. 

Best Gold Stocks To Watch For 2021: Northgate Minerals Corporation(NXG)

Northgate Minerals Corporation, together with its subsidiaries, engages in exploring, developing, processing, and mining gold and copper deposits in Canada and Australia. Its principal producing assets include 100% interests in the Fosterville and Stawell Gold mines in Victoria, Australia; and the Kemess South mine located in north-central British Columbia, Canada. The company was formerly known as Northgate Exploration Limited and changed its name to Northgate Minerals Corporation in May 2004. Northgate Minerals Corporation was founded in 1919 and is headquartered in Toronto, Canada.

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).

Best Gold Stocks To Watch For 2021: NEW GOLD INC.(NGD)

New Gold Inc. engages in the acquisition, exploration, extraction, processing, and reclamation of mineral properties. The company primarily explore for gold, silver, and copper deposits. Its operating properties include the Mesquite gold mine in the United States; the Cerro San Pedro gold-silver mine in Mexico; and the Peak gold-copper mine in Australia. The company also has development projects, including the New Afton gold, silver, and copper project in Canada; and a 30% interest in the El Morro copper-gold project in Chile. The company was formerly known as DRC Resources Corporation and changed its name to New Gold Inc. in June 2005. New Gold Inc. was founded in 1980 and is headquartered in Vancouver, Canada.

Advisors’ Opinion:

  • [By Ethan Ryder]

    ILLEGAL ACTIVITY NOTICE: “New Gold Inc (NGD) Short Interest Down 3.5% in March” was published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/4282582/new-gold-inc-ngd-short-interest-down-3-5-in-march.html.

  • [By Ethan Ryder]

    New Gold (NYSEAMERICAN:NGD) had its price objective lowered by analysts at Royal Bank of Canada from $1.25 to $1.00 in a research report issued on Wednesday. The brokerage currently has an “underperform” rating on the basic materials company’s stock. Royal Bank of Canada’s target price indicates a potential upside of 14.50% from the stock’s current price.

  • [By Matthew DiLallo]

    Shares of New Gold (NYSEMKT:NGD) sold off on Thursday, plunging more than 20% by 11 a.m. EST after the gold mining company reported its fourth-quarter results as well as its outlook for 2019.

  • [By WWW.GURUFOCUS.COM]

    For the details of Exor Investments (UK) LLP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Exor+Investments+%28UK%29+LLP

    These are the top 5 holdings of Exor Investments (UK) LLPSibanye-Stillwater (SBGL) – 45,970,311 shares, 32.51% of the total portfolio. Shares added by 8.09%VEON Ltd (VEON) – 37,657,792 shares, 31.02% of the total portfolio. Shares added by 3.83%Cameco Corp (CCJ) – 5,967,410 shares, 19.32% of the total portfolio. Harmony Gold Mining Co Ltd (HMY) – 13,275,728 shares, 6.26% of the total portfolio. Shares added by 6.84%Novagold Resources Inc (NG) – 5,889,905 shares, 6.21% of the total portfolio. Shares

Top 10 Growth Stocks To Own For 2021

This post was written by Hamish Kumar, Integer Investments analyst.

Investment Thesis

Constellation Brands’ (NYSE:STZ) FY2017 results emphasize the company’s strong qualitative factors and earnings power. Despite trading near its 52-week high, we still believe the stock is a worthy buy.

What Does The Company Do?

Constellation Brands produces, imports and markets beer, wine and spirits in the United States, Canada, Mexico, New Zealand and Italy. The company sells wine across various categories, including table wine, sparkling wine and dessert wine. Notable brand offerings include the Corona beer range, the Modelo beer range, SVEDKA vodka, Casa Noble tequila and Black Box wine. The company primarily offers its products to wholesale distributors and retailers in the United States.

Top 10 Growth Stocks To Own For 2021: TrueBlue Inc.(TBI)

TrueBlue, Inc. provides temporary blue-collar staffing services in the United States. It supplies on demand general labor to various industries under the Labor Ready brand; skilled labor to manufacturing and logistics industries under the Spartan Staffing brand; and trades people for commercial, industrial, and residential construction, and building and plant maintenance industries under the CLP Resources brand. The company also provides mechanics and technicians to the aviation maintenance, repair and overhaul, aerospace manufacturing, and assembly industries, as well as to other transportation industries under the Plane Techs brand; and temporary drivers to the transportation and distribution industries under the Centerline brand. It primarily serves small and medium-size businesses. The company was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. TrueBlue, Inc. was founded in 1985 and is headquartered in Tacoma, Washington.

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine downgraded shares of Trueblue (NYSE:TBI) from a hold rating to a sell rating in a report issued on Friday morning.

    Several other research firms have also recently weighed in on TBI. Zacks Investment Research cut shares of Trueblue from a hold rating to a sell rating in a research report on Tuesday, February 12th. BMO Capital Markets decreased their price objective on shares of Trueblue from $26.00 to $24.00 and set a market perform rating for the company in a research report on Monday, February 11th. TheStreet cut shares of Trueblue from a b- rating to a c rating in a research report on Monday, December 31st. Finally, Credit Suisse Group decreased their price objective on shares of Trueblue from $31.00 to $25.00 and set a hold rating for the company in a research report on Tuesday, November 6th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Trueblue presently has an average rating of Hold and a consensus price target of $26.00.

  • [By Motley Fool Transcribers]

    TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 Growth Stocks To Own For 2021: MEDIFAST INC(MED)

Medifast, Inc., through its subsidiaries, engages in the production, distribution, and sale of weight management and disease management products, and other consumable health and diet products in the United States. The company?s product lines include weight and disease management, meal replacement, and vitamins. It also operates weight control centers that offer Medifast programs for weight loss and maintenance, customized patient counseling, and inbody composition analysis. The company markets its products under the Medifast and Essential brand names, including shakes, appetite suppression shakes, women?s health shakes, diabetics shakes, joint health shakes, coronary health shakes, calorie burn drinks, calorie burn flavor infusers, antioxidant shakes, antioxidant flavor infusers, bars, crunch bars, soups, chili, oatmeal, pudding, scrambled eggs, hot cocoa, cappuccino, chai latte, iced teas, fruit drinks, pretzels, puffs, brownie, pancakes, soy crisps, crackers, and omega 3 and digestive health products. Medifast Inc. sells its products through various channels of distribution comprising Web, call center, independent health advisors, medical professionals, weight loss clinics, and direct consumer marketing supported via the phone and the Web; Take Shape for Life, a physician led network of independent health coaches; and weight control centers. The company was founded in 1980 and is headquartered in Owings Mills, Maryland.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Medifast Inc  (NYSE:MED)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    MediBloc [MED] (CURRENCY:MED) traded 11.7% lower against the U.S. dollar during the 1 day period ending at 20:00 PM ET on February 16th. MediBloc [MED] has a total market capitalization of $19.63 million and $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours. During the last seven days, MediBloc [MED] has traded down 27.6% against the U.S. dollar. One MediBloc [MED] token can currently be bought for $0.0066 or 0.00000100 BTC on major exchanges including Coinrail, Bibox and Gate.io.

Top 10 Growth Stocks To Own For 2021: Intuitive Surgical Inc.(ISRG)

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Its da Vinci surgical system consists of a surgeon?s console or consoles, a patient-side cart, a 3-D vision system, and proprietary ?wristed? instruments. The company?s da Vinci surgical system translates the surgeon?s natural hand movements on instrument controls at the console into corresponding micro-movements of instruments positioned inside the patient through small puncture incisions, or ports. It also manufactures a range of EndoWrist instruments, which incorporate wrist joints for natural dexterity for various surgical procedures. Its EndoWrist instruments consist of forceps, scissors, electrocautery, scalpels, and other surgical tools. In addition, it sells various vision and accessory products for use in conjunction with the da Vinci Surgical System as surgical procedures are performed. The company?s accessory products include sterile drapes used to ensure a sterile field during surgery; vision products, such as replacement 3-D stereo endoscopes, camera heads, light guides, and other items. It markets its products through sales representatives in the United States, and through sales representatives and distributors in international markets. The company was founded in 1995 and is headquartered in Sunnyvale, California.

Advisors’ Opinion:

  • [By Motley Fool Staff]

    For this episode, it’s time to check in on not one but two such samplers. First, it’s been one year since he offered up “Five Stocks I Own That You Should Too.” Those were Activision Blizzard (NASDAQ:ATVI), Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Intuitive Surgical (NASDAQ:ISRG), Match Group (NASDAQ:MTCH), and Zillow (NASDAQ:Z) (NASDAQ:ZG), and he’ll review their progress with senior analyst Jim Mueller.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intuitive Surgical (ISRG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Growth Stocks To Own For 2021: Buffalo Wild Wings Inc.(BWLD)

Buffalo Wild Wings, Inc. engages in the ownership, operation, and franchise of restaurants in the United States. The company provides quick casual and casual dining services, as well as serves bottled beers, wines, and liquor. As of July 26, 2011, it had 773 Buffalo Wild Wings locations in 45 states in the United States, as well as in Canada. The company was founded in 1982 and is headquartered in Minneapolis, Minnesota.

Advisors’ Opinion:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:

Top 10 Growth Stocks To Own For 2021: Nordstrom Inc.(JWN)

Nordstrom, Inc., a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for women, men, and children in the United States. It offers a selection of brand name and private label merchandise. The company sells its products through various channels, including Nordstrom full-line stores, off-price Nordstrom Rack stores, Jeffrey? boutiques, treasure & bond, and Last Chance clearance stores; and its online store, nordstrom.com, as well as through catalog. Nordstrom also provides a private label card, two Nordstrom VISA credit cards, and a debit card for Nordstrom purchases. The company?s credit and debit cards feature a shopping-based loyalty program. As of September 30, 2011, it operated 222 stores, including 117 full-line stores, 101 Nordstrom Racks, 2 Jeffrey boutiques, 1 treasure & bond store, and 1 clearance store in 30 states. The company was founded in 1901 and is based in Seattle, Washington.

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Over the past decade, Nordstrom (NYSE:JWN) has been one of the most forward-thinking department stores in terms of rolling out new technology and testing innovative ways to serve customers. However, you wouldn’t know it from the company’s financial results.

  • [By Garrett Baldwin]

    Now, here’s a closer look at today’s Money Morning insight, the most important market events, and stocks to watch.

    The Top Stock Market Stories for Friday
    Bloomberg reported Thursday that the United States and China are getting closer to finalizing a trade deal that would eliminate tariffs and improve relations between the world’s two largest economies. According to reports, the deal would be completed and signed by both U.S. President Donald Trump and Chinese President Xi Jinping by mid-May. Trade officials have said that both countries are making steady progress on a deal and that more updates are coming soon. Money Morning Special Contributor Matt Piepenburg shows you how to trade the ongoing developments between the United States and China right here. The earnings season continued today with a wave of news in the retail sector. First, Gap Inc. (NYSE: GPS) announced plans to split into two separate public companies. Its Old Navy brand will become a standalone company, while its Gap and Banana Republic brands remain under the same organization. GPS shares popped 21% on the news. Meanwhile, Nordstrom Inc. (NYSE: JWN) added 1.5% after the firm released a 2019 outlook that topped Wall Street expectations. New York Governor Andrew Cuomo is trying to save a deal with Amazon.com Inc. (NASDAQ: AMZN). According to CNBC, the governor is asking the e-commerce giant to reconsider its decision to abandon a plan to open a second headquarters in Long Island City. Last month, Amazon walked away from a plan to create 25,000 jobs (at an average salary of $150,000) after pushback from local public officials. The company was to receive $3 billion in tax incentives. The New York Times reported Thursday that Cuomo had numerous conversations with Amazon executives about reconsidering company plans.
    Money Morning Insight of the Day

    We just held a live event with former Speaker of the House John Boehner and the most powerful people in the cannabis world for one important rea

  • [By Motley Fool Transcribing]

    Nordstrom (NYSE:JWN) Q4 2018 Earnings Conference CallFeb. 28, 2019 4:45 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Garrett Baldwin]

    Before the bell, the U.S. Bureau of Economic Analysis reported its second GDP estimate for the fourth quarter. U.S. economic growth came in at 2.6%, a figure that topped consensus expectations. Q2 and Q3 2018 GDP growth came in at fabulous levels – 4.2% and 3.4%, respectively. However, investors predicted the reading would come in lower due to the government shutdown during the fourth quarter. In other economic news, the Department of Labor this morning reported weekly jobless claims at 225,000. That figure is slightly higher than the 220,000 expected by economists. The price of Bitcoin is currently hovering just under $4,000. We’ve been watching a long process of consolidation at these levels for several weeks. Despite short-term pain in the markets, Money Morning’s David Zeiler outlines the bullish case for Bitcoin. How high can the price of Bitcoin go? David makes the bullish case that Bitcoin could hit $250,000 by 2025. For more on how to profit from Bitcoin’s next bull cycle, go here now.
    Stocks to Watch Today: JCP, JWN, ACI, BUD
    Shares of J.C. Penney Co. Inc. (NYSE: JCP) popped more than 16% after the embattled retail giant reported earnings. The company topped Wall Street expectations and announced plans to shutter another 18 department stores this year. The company’s balance sheet temporarily improved after it was able to reduce its massive inventory glut. The firm reported EPS of $0.18, topping forecasts by $0.08. Revenue came in at $3.79 billion. Shares of Anheuser Busch Inbev NV (NYSE: BUD) popped more than 5% after the beer brewing giant crushed Wall Street earnings expectations. The Budweiser and Corona maker announced plans to increase its non-alcoholic and low-alcohol drinks business, two areas that continue to show impressive and rising global demand. The Western Union Co. (NYSE: WU) is generating buzz after it announced a $1 billion stock buyback program. In addition, the payment giant said it would sell its Speedpay bill paying bu

Top Cheap Stocks For 2021

Lendingtree (NASDAQ:TREE) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

According to Zacks, “LendingTree is the nation’s leading online loan marketplace, empowering consumers as they comparison-shop across a full suite of loan and credit-based offerings. LendingTree provides an online marketplace which connects consumers with multiple lenders that compete for their business, as well as an array of online tools and information to help consumers find the best loan. Since inception, LendingTree has facilitated more than 55 million loan requests. LendingTree provides free monthly credit scores through My LendingTree and access to its network of over 350 lenders offering home loans, personal loans, credit cards, student loans, business loans, home equity loans/lines of credit, auto loans and more. LendingTree, LLC is a subsidiary of LendingTree, Inc. “

Top Cheap Stocks For 2021: Kohl’s Corporation(KSS)

Kohl?s Corporation operates department stores in the United States. The company?s stores offer private and exclusive, as well as national branded apparel, footwear, and accessories for women, men, and children; soft home products, such as sheets and pillows; and housewares primarily to middle-income customers. As of January 29, 2011, it operated 1,089 stores in 49 states. The company also offers on-line shopping on its Web site at Kohls.com. Kohl?s Corporation was founded in 1962 and is headquartered in Menomonee Falls, Wisconsin.

Advisors’ Opinion:

  • [By Logan Wallace]

    Kohl’s Co. (NYSE:KSS) – Investment analysts at Jefferies Financial Group upped their Q2 2020 earnings per share (EPS) estimates for shares of Kohl’s in a report issued on Tuesday, March 5th. Jefferies Financial Group analyst R. Konik now expects that the company will post earnings of $1.90 per share for the quarter, up from their prior estimate of $1.86. Jefferies Financial Group also issued estimates for Kohl’s’ Q3 2020 earnings at $1.04 EPS, Q4 2020 earnings at $2.48 EPS, FY2020 earnings at $6.10 EPS and FY2021 earnings at $6.45 EPS.

  • [By Adam Levine-Weinberg]

    A few years ago, Kohl’s (NYSE:KSS) management determined that many of the department store chain’s stores were too big. In many cases, Kohl’s was filling these stores with more inventory than was necessary to meet demand, just so the stores wouldn’t look empty. That excess inventory led to margin-sapping clearance discounts at the end of each season.

Top Cheap Stocks For 2021: Emerson Electric Company(EMR)

Emerson Electric Co. operates as a diversified manufacturing and technology company. The company engages in appliance solutions, climate technologies, industrial automation, motor technology, network power, process management, professional tools, and storage solutions businesses. Its appliance solutions business provides appliance controls, appliance motors, heating products, and white-rodgers; climate technology business provides heating, ventilation, air conditioning, and refrigeration (HVACR) solutions for residential, industrial, and commercial applications; and industrial automation business offers bearings and power transmission products, electrical power generation products, electric motors, variable speed drives and servos, electrical products, material joining solutions, fluid automation products, and wind turbine systems. The company?s motor technology business provides appliance motors, HVACR motors, DC motors, fractional horsepower motors, integral horsepower a nd larger motors, and drives; network power business provides power, precision cooling, connectivity, and embedded solutions; and process management business provides various wireless related products from self-organizing field networks to wireless asset and people tracking. Its professional tools business offers pipe working and threading equipment, pressing technology, utility locating and visual diagnostics systems, drain maintenance tools, power tools, air tools, general purpose hand tools, wet/dry vacs, job site storage equipment, truck tool boxes and equipment, and van storage equipment; and storage solutions business provides shelving and storage products for residential, commercial, and foodservice needs, as well as offers specialized carts, mobile computer workstations, and cabinet fixtures. The company was founded in 1890 and is headquartered in St. Louis, Missouri.

Advisors’ Opinion:

  • [By Lee Samaha]

    In PMT, Honeywell’s process-solutions rival Emerson Electric (NYSE:EMR) continues to report strong results. But whereas Emerson’s CEO David Farr is expecting to benefit from relatively stronger LNG (liquefied natural gas) spending in the current cycle, Honeywell’s LNG revenue accounts for just 5% of its PMT sales, and it’s more heavily exposed to petrochemical and refining spending.

  • [By ]

    Emerson Electric Co. (NYSE: EMR) offers technology and engineering solutions to industrial, commercial and consumer markets. While it has had exposure to oil and gas, the company is poised for earnings growth, and its dividend hike in November of 2018 marked the 62nd straight year of dividend hikes.

  • [By Stephan Byrd]

    Truehand Inc purchased a new position in shares of Emerson Electric Co. (NYSE:EMR) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 34,486 shares of the industrial products company’s stock, valued at approximately $2,061,000. Emerson Electric makes up 1.8% of Truehand Inc’s investment portfolio, making the stock its 19th largest position.

  • [By Lee Samaha]

    Emerson Electric (NYSE:EMR) recently had its first-quarter 2019 earnings call, and one week later held an investor conference where CEO David Farr laid out his medium-term outlook. The key takeaway from both events is that Emerson Electric’s immediate guidance has some uncertainty around it, but unless you believe that the global economy will slow notably in the next few years, the stock looks like a good value for income-seeking investors. Here’s why.

Top Cheap Stocks For 2021: Wendy’s/Arby’s Group Inc.(WEN)

The Wendy’s Company operates as a quick-service hamburger company in the United States. The company, through its subsidiary, Wendy’s International, Inc., operates as a franchisor of the Wendy’s restaurant system. As of December 26, 2011, the Wendy’s system comprised approximately 6,500 franchise and company restaurants in the United States and the United States territories, as well as in 26 other countries worldwide. The company was formerly known as Wendy’s/Arby’s Group, Inc. and changed its name to The Wendy’s Company in July 2011. The Wendy’s Company was founded in 1884 and is headquartered in Dublin, Ohio.

Advisors’ Opinion:

  • [By ]

    There is certainly a growing market for vegan products. But Beyond Meat has only taken in a scant $56 million in revenues over the past nine months and is nowhere near profitability. By contrast, Wendy’s (NYSE: WEN) has 6,700 global locations that generate $1.6 billion in annual sales and $230 million in free cash flow — not to mention a dividend that was just raised by 18%.

  • [By Max Byerly]

    Wentworth Resources (LON:WEN) had its price target cut by Peel Hunt from GBX 44 ($0.57) to GBX 42 ($0.55) in a report released on Monday. The brokerage presently has a “buy” rating on the stock. Peel Hunt’s target price would indicate a potential upside of 82.61% from the company’s current price.

  • [By Todd Campbell]

    He’s been the non-executive chairman of Wendy’s(NASDAQ:WEN) since June 2007 and a director at Wendy’s since 1993. He’s also an independent director of Sysco, a food distributor; an independent director ofMadison Square Garden; and a former director atH.J. Heinz and Kraft Heinz Foods.

  • [By Stephan Byrd]

    Wentworth Resources (LON:WEN)’s stock had its “buy” rating reaffirmed by Peel Hunt in a research report issued to clients and investors on Thursday.

Top Cheap Stocks For 2021: Express-1 Expedited Solutions Inc.(XPO)

XPO Logistics, Inc. provides third-party logistics services using a network of relationships with ground, sea, and air carriers in the United States, Mexico, and Canada. It operates in three segments: Express-1, Concert Group Logistics, and Bounce Logistics. The Express-1 segment offers ground expedited surface transportation services for freight. It operates a fleet ranging from cargo vans to semi tractor trailer units. The Concert Group Logistics segment provides domestic and international freight forwarding services through a network of independently owned stations. Its domestic freight forwarding services include air charter, expedites, and time sensitive services, as well as cost sensitive services comprising deferred delivery, less than truckload, and full truck load services; and international freight forwarding services consist of on-board courier and air charters, time sensitive services, less-than-container and full-container-loads, and vessel charters. This segm ent also offers documentation on international shipments, customs clearance and banking, trade show shipment management, time definite and customized product distributions, reverse logistics and on site asset recovery projects, installation coordination, freight optimization, and diversity compliance support services. The Bounce Logistics segment provides premium freight brokerage services for truckload shipments. The company serves approximately 4,000 retail, commercial, manufacturing, and industrial customers through 6 U.S. operations centers and 22 agent locations. It offers its services to the automotive manufacturing, automotive components and supplies, commercial printing, durable goods manufacturing, pharmaceuticals, food and consumer products, and high tech sectors. The company was formerly known as Express-1 Expedited Solutions, Inc. and changed its name to XPO Logistics, Inc. in September 2011. XPO Logistics, Inc. was founded in 1989 and is based in Buchanan, Michi gan.

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday was an extremely strong day for the stock market, as major indexes finished well above where they started the session. Favorable economic data on retail sales renewed confidence that the U.S. economy continues to do well despite headwinds elsewhere around the world, and investors were pleased to see the U.S. and China discuss their respective currencies as part of their broader trade talks. Some benchmarks rose as much as 2%, but certain individual stocks saw even larger gains. NVIDIA (NASDAQ:NVDA), XPO Logistics (NYSE:XPO), and Infinera (NASDAQ:INFN) were among the top performers. Here’s why they did so well.

  • [By Neha Chamaria]

    XPO Logistics (NYSE:XPO) is having a hard time winning back investor confidence. Shares of the logistics company slumped 17.2% in February, according to data provided byS&P Global Market Intelligence, giving up all its gains from January and then some. In fact, the stock continues to head lower this month, having dropped another 4% as of this writing.

  • [By Motley Fool Staff]

    XPO Logistics (NYSE:XPO) has grown fantastically in recent years by aggressively acquiring related businesses. However, management recently announced its intention to pause its acquisition strategy in favor of repurchasing shares.

  • [By Motley Fool Staff]

    As e-commerce has exploded over the past decade, supply chains have had to adapt to new demands. In particular, logistics has become vastly more complicated. To better serve customers as consumer preferences change, XPO Logistics (NYSE:XPO) has developed expertise in last-mile delivery, specifically targeting heavy packages like furniture and appliances.

Top Cheap Stocks For 2021: S&P Smallcap 600(PH)

Parker Hannifin Corporation manufactures fluid power systems, electromechanical controls, and related components worldwide. Its Industrial segment offers pneumatic and electromechanical components, and systems; filters, systems, and instruments to monitor and remove contaminants from fuel, air, oil, water, and other liquids and gases; connectors that control, transmit, and contain fluid; hydraulic components and systems for builders and users of industrial and mobile machinery and equipment; critical flow components for process instrumentation, healthcare, and ultra-high-purity applications; and static and dynamic sealing devices. This segment sells its products to original equipment manufacturers (OEMs) and their replacement markets in the manufacturing, transportation, and processing industries. The company?s Aerospace segment provides flight control systems and components, including hydraulic, electrohydraulic, electric backup hydraulic, electrohydrostatic, and electro -mechanical components for precise control of aircraft rudders, elevators, ailerons, and other aerodynamic control surfaces. It also provides electronics thermal management heat rejection systems, and single-phase and two-phase heat collection systems for radar, ISAR, and power electronics. This segment markets its products primarily to OEMs in the commercial, military, and general aviation markets, as well as to end users. Its Climate and Industrial Controls segment offers systems and components primarily for use in the mobile and stationary refrigeration, and air conditioning industry; and in fluid control applications in various industries, such as processing, fuel dispensing, beverage dispensing, and mobile emissions. This segment serves OEMs and their replacement markets. Parker-Hannifin Corporation markets its products through direct-sales employees, independent distributors, wholesalers, and sales representatives. The company was founded in 1918 and is headquartered i n Cleveland, Ohio.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Commerzbank Aktiengesellschaft FI increased its holdings in shares of Parker-Hannifin Corp (NYSE:PH) by 9.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,709 shares of the industrial products company’s stock after acquiring an additional 3,348 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Parker-Hannifin were worth $5,624,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Parker-Hannifin (NYSE:PH) had its price target boosted by Wells Fargo & Co from $185.00 to $193.00 in a research note released on Thursday, The Fly reports. Wells Fargo & Co currently has a market perform rating on the industrial products company’s stock.

Best Low Price Stocks To Invest In 2021

The pound stayed close to a more than one-year low against the dollar after data showing accelerating economic growth were offset by concerns about a no-deal Brexit.

Sterling was set for its fifth week of declines — its longest losing streak since January 2015 — amid continued fears that the divorce negotiations between the U.K. and the European Union may end without agreement. The U.K. economy grew 1.3 percent in the second quarter from a year earlier, matching the median economist forecast, while manufacturing expanded more than expected.

Best Low Price Stocks To Invest In 2021: Humana Inc.(HUM)

Humana Inc. offers various health and supplemental benefit plans in the United States. Its Government segment consists of beneficiaries of government benefit programs; and operates in three lines of businesses, including Medicare, Military, and Medicaid. The Medicare program provides hospital and medical insurance benefits to persons of age 65 and over and some disabled persons under the age of 65. The Military program offers health insurance coverage to the dependents of duty military personnel, and to retired military personnel and their dependents. The Medicaid program is a federal program that is state-operated to facilitate the delivery of health care services primarily to low-income residents. The Commercial segment consists of members enrolled in its medical and specialty products marketed to employer groups and individuals. This segment provides health maintenance organization products that offer prepaid health insurance coverage to its members through a network of independent primary care physicians, specialty physicians, and other health care providers; preferred provider organization products, which are offered primarily to employer groups and individuals; and administrative services only products that are provided to employers who self-insure their employee health plans. It also offers various specialty products, including dental, vision, and other supplemental products, as well as disease management services. As of December 31, 2010, Humana Inc. had approximately 10.2 million members enrolled in medical benefit plans; and approximately 7.1 million members enrolled in specialty products programs. The company markets its products through various channels comprising television, radio, the Internet, telemarketing, and direct mailings. In addition, it has strategic alliances with Wal-Mart Stores, Inc.; State Farm; and United Services Automobile Association to market its products. The company was founded in 1961 and is headquartered in Louisville, Kentucky.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Traders bought shares of Humana Inc (NYSE:HUM) on weakness during trading hours on Monday. $146.79 million flowed into the stock on the tick-up and $70.85 million flowed out of the stock on the tick-down, for a money net flow of $75.94 million into the stock. Of all stocks tracked, Humana had the 6th highest net in-flow for the day. Humana traded down ($4.81) for the day and closed at $304.87

  • [By Ethan Ryder]

    Humana Inc (NYSE:HUM) – Piper Jaffray Companies upped their Q3 2019 EPS estimates for Humana in a note issued to investors on Sunday, September 30th. Piper Jaffray Companies analyst S. James now anticipates that the insurance provider will post earnings of $4.86 per share for the quarter, up from their previous estimate of $4.74. Piper Jaffray Companies has a “Overweight” rating and a $380.00 price objective on the stock. Piper Jaffray Companies also issued estimates for Humana’s Q4 2019 earnings at $3.51 EPS.

  • [By Stephan Byrd]

    Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 1st. The insurance provider reported $3.96 EPS for the quarter, topping analysts’ consensus estimates of $3.79 by $0.17. Humana had a return on equity of 17.43% and a net margin of 2.48%. The business had revenue of $14.26 billion during the quarter, compared to analysts’ expectations of $14.16 billion. During the same quarter last year, the company posted $3.49 earnings per share. sell-side analysts predict that Humana Inc will post 14.18 EPS for the current year.

  • [By Max Byerly]

    Metropolitan Life Insurance Co. NY increased its holdings in shares of Humana Inc (NYSE:HUM) by 0.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 27,617 shares of the insurance provider’s stock after acquiring an additional 234 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Humana were worth $8,220,000 at the end of the most recent quarter.

Best Low Price Stocks To Invest In 2021: Cherry Hill Mortgage Investment Corporation(CHMI)

Cherry Hill Mortgage Investment Corporation, incorporated on October 31, 2012, is a residential real estate finance company. The Company is focused on acquiring, investing in and managing residential mortgage assets in the United States. Its principal objective is to generate attractive current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The Company focuses on attaining this objective, subject to market conditions and availability and terms of financing, by selectively constructing and managing a targeted portfolio of Servicing Related Assets, residential mortgage-backed securities (RMBS), prime mortgage loans and other cashflowing residential mortgage assets. The Company operates its business through segments, including investments in RMBS; investments in Servicing Related Assets, and All Other. The Company’s targeted asset classes include servicing related assets consisting of mortgage servicing rights (MSRs) and Excess MSRs; RMBS, including Agency RMBS, residential mortgage pass-through certificates, collateralized mortgage obligations (CMOs) (interest-only security (IO) and inverse IOs) and to-be-announced (TBA), and prime mortgage loans. The Company is externally managed by Cherry Hill Mortgage Management, LLC.

The Company also may generate MSRs through the purchase of prime mortgage loans. Its RMBS strategy focuses primarily on the acquisition and ownership of Agency RMBS that are whole-pool, residential mortgage pass-through certificates. However, from time to time, the Company invests in CMOs, including IOs and inverse IOs. Its RMBS strategy includes selective investments in non-Agency RMBS, including government-sponsored enterprise (GSE) risk-sharing securities.

Advisors’ Opinion:

  • [By Max Byerly]

    Cherry Hill Mortgage Investment (NYSE:CHMI) and Great Portland Estates (OTCMKTS:GPEAF) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

  • [By Ethan Ryder]

    Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cherry Hill Mortgage Investment Corp (NYSE:CHMI) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 152,335 shares of the real estate investment trust’s stock, valued at approximately $2,721,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.98% of Cherry Hill Mortgage Investment as of its most recent filing with the SEC.

Best Low Price Stocks To Invest In 2021: Carrizo Oil & Gas, Inc.(CRZO)

Carrizo Oil & Gas, Inc. is a Houston-based energy company which, together with its subsidiaries (collectively, “Carrizo,” the “Company” or “we”), is actively engaged in the exploration, development, and production of oil and gas primarily from resource plays located in the United States. Our current operations are principally focused in proven, producing oil and gas plays primarily in the Eagle Ford Shale in South Texas, the Delaware Basin in West Texas, the Utica Shale in Ohio, the Niobrara Formation in Colorado and the Marcellus Shale in Pennsylvania. The Company achieved record total production in 2015 of 13.4 MMBoe, a 12% increase from 2014, despite significantly lower capital expenditures in 2015 when compared to 2014. At year-end 2015, our proved reserves of 170.6 MMBoe were 64% crude oil, 12% natural gas liquids and 24% natural gas. Our reserves increased primarily as a result of our ongoing drilling program in the Eagle Ford.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Carrizo Oil & Gas (NASDAQ:CRZO)’s stock had its “buy” rating reaffirmed by investment analysts at Northland Securities in a report issued on Tuesday. They currently have a $25.00 price objective on the oil and gas producer’s stock. Northland Securities’ price target would suggest a potential upside of 109.21% from the company’s previous close.

  • [By Max Byerly]

    BidaskClub upgraded shares of Carrizo Oil & Gas (NASDAQ:CRZO) from a hold rating to a buy rating in a report published on Wednesday morning.

    Several other research firms have also commented on CRZO. Royal Bank of Canada reissued a buy rating and set a $29.00 price target on shares of Carrizo Oil & Gas in a research report on Thursday, July 12th. Zacks Investment Research lowered shares of Carrizo Oil & Gas from a buy rating to a hold rating in a research report on Thursday, July 26th. Stifel Nicolaus cut their price objective on shares of Carrizo Oil & Gas from $44.00 to $34.00 and set a buy rating on the stock in a report on Thursday, June 28th. Jefferies Financial Group restated a hold rating and set a $27.00 price objective on shares of Carrizo Oil & Gas in a report on Wednesday, July 18th. Finally, Williams Capital restated a buy rating and set a $41.00 price objective on shares of Carrizo Oil & Gas in a report on Monday, July 23rd. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $29.58.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Carrizo Oil & Gas (CRZO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Carrizo Oil & Gas Inc (NASDAQ:CRZO) – Equities research analysts at US Capital Advisors raised their Q1 2019 EPS estimates for shares of Carrizo Oil & Gas in a note issued to investors on Thursday, August 30th. US Capital Advisors analyst C. Horwitz now forecasts that the oil and gas producer will post earnings of $0.98 per share for the quarter, up from their previous estimate of $0.87. US Capital Advisors also issued estimates for Carrizo Oil & Gas’ Q2 2019 earnings at $1.10 EPS, Q3 2019 earnings at $1.21 EPS and Q4 2019 earnings at $1.27 EPS.

Top 10 Biotech Stocks To Watch Right Now

Priceline Group (NASDAQ:PCLN) was a top contributor during the first quarter as they continue to execute their strategy of connecting the supply of heavily fragmented, independent hospitality providers—primarily in international markets—with demand from the Company’s rapidly expanding user base. While we recognize that the online travel agency (OTA) market in the U.S. has matured, there remains a sizable addressable international market in which Priceline continues to aggressively reinvest, primarily, in organic growth opportunities. From a supply perspective, Priceline Group’s Booking.com site has amassed listings on over 500,000 “alternative” properties—all of which are available for online booking-in addition to well over 600,000 conventional hospitality properties. We believe the value proposition of renting a private residence (i.e., alternative property) is still substantially different from traditional hospitality services, and represents an incremental revenue opportunity for Booking.com. Last, while the multiple on the stock has expanded over the past few quarters, we continue to view Priceline’s valuation as one of the more attractive multiples in our universe, relative to the Company’s exceptional growth, and cash-rich balance sheet.

From David Rolfe (Trades, Portfolio)’s Wedgewood Partners first-quarter 2017 shareholder letter.

Top 10 Biotech Stocks To Watch Right Now: Biogen Idec Inc(BIIB)

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t he treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer’s disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.

Advisors’ Opinion:

  • [By ]

    Just last Thursday, March 21, Biogen (Nasdaq: BIIB) and its partner, Japanese biopharmaceutical company Eisai (OTC: ESALY), said that their experimental Alzheimer’s therapy, which at that time was at the second stage of clinical trials, was a bust. BIIB dropped 29.2% on the day, and ESALY by 35% on the same day.

  • [By Chris Hill]

    In this episode of Motley Fool Money, host Chris Hill and analysts Emily Flippen, Jim Mueller, and Jason Moser hit on some of the biggest recent news in the market. Disney (NYSE:DIS) finishes up its merger with Fox, and it’s ready to take on a crowded streaming space. CVS Health (NYSE:CVS) diversifies into CBD lotion. Levi Strauss (NYSE:LEVI) enters the public markets with a bafflingly high market cap, while Nike (NYSE:NKE) sells off on higher-than-expected revenue and profits. Biogen’s (NASDAQ:BIIB) biggest trial bombs, and the stock tanks along with it. Papa John’s (NASDAQ:PZZA) welcomes Shaq into its board of directors. And, as always, the analysts share some stocks on their radar. Plus, stay tuned for an interview with Lake House Capital’s Joe Magyer about investing in Australia — the biggest trends, biggest worries, and some Aussie picks to add to your watch list.

  • [By Garrett Baldwin]

    Nike Inc. (NYSE: NKE) will lead a busy day of earnings reports. The firm expects that its year-over-year sales will have increased by 7%. The company’s stock slumped in February after Duke basketball player Zion Williamson was hurt blowing out his sneaker in the first minute of a major contest against North Carolina. Expect analysts to ask a lot of questions about Nike’s expectations for global economic growth and its exposure to a weakening Chinese economy.
    Stocks to Watch Today: BIIB, BA, LEVI
    Shares of Biogen Inc. (NASDAQ: BIIB) plunged more than 25% after the company announced a major setback for a key Alzheimer’s drug. The biotech giant announced that its experimental drug “aducanumab” is unlikely to be effective for mass deployment and that it will halt its research. One analyst described this as a “transformative failure for Biogen’s pipeline.” This is a massive setback for one of the top biotech companies in the world. Shares of Boeing Co. (NYSE: BA) are off again Thursday on news that the investigation into its 737 Max jets has expanded. According to reports, the FBI has now joined a federal investigation into the certification process for the jet. The Department of Transportation launched an audit of the Federal Aviation Administration’s approval of the jet, which received certification two years ago. Boeing and the FAA have faced global scrutiny over two fatal crashes involving the 737 Max jet series and news of previous pilot complaints about the planes. Levi Strauss & Co. (NYSE: LEVI) will return to the public markets for the first time in 34 years. The iconic apparel company will launch its IPO today with a price of $17 per share. That would set the company’s market capitalization at $6.6 billion. Look for other earnings reports from Canadian Solar Inc. (NASDAQ: CSIQ), Cintas Corp. (NASDAQ: CTAS), CNOOC Ltd. (NYSE: CEO), Conagra Brands Inc. (NYSE: CAG), Darden Restaurants Inc. (NYSE: DRI), and Lands’ End Inc. (NYSE: LE).
    Public Law 92-

  • [By Money Morning News Team]

    Biogen Inc. (NASDAQ: BIIB) is a Massachusetts-based company that focuses on discovering, developing, manufacturing, and delivering therapies for neurodegenerative and neurological diseases worldwide.

Top 10 Biotech Stocks To Watch Right Now: ArQule Inc.(ARQL)

ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. Its lead product ARQ 197 is non-adenosine triphosphate competitive inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in non-small cell lung cancer, c-Met-associated soft tissue sarcomas, pancreatic adenocarcinoma, hepatocellular carcinoma, germ cell tumors, and colorectal cancer. The company is also developing ARQ 621, a Phase I program focused on inhibition of the Eg5 kinesin spindle protein. Its clinical stage products include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. In addition, the company involves in pre-clinical development o f B-RAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.

Advisors’ Opinion:

  • [By Cory Renauer]

    It isn’t unusual for oncology stocks to double in a single day after a company announces clinical trial results. Arqule (NASDAQ:ARQL) stands out among its peers because it notched a 67% gain after reporting a partial remission for just one leukemia patient.

  • [By Motley Fool Transcribers]

    Arqule Inc  (NASDAQ:ARQL)Q4 2018 Earnings Conference CallMarch 07, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Dan Caplinger]

    Thursday was another down day for the stock market, with new pressure coming from international moves on the macroeconomic front. The European Central Bank signaled that it was ready to provide more accommodative monetary policy, reversing a previous tightening stance and showing its concerns about the prospects for economic growth in the region. Yet favorable earnings reports continued lifting shares of certain individual companies. Rosetta Stone (NYSE:RST), ArQule (NASDAQ:ARQL), and Fly Leasing (NYSE:FLY) were among the top performers. Here’s why they did so well.

  • [By Maxx Chatsko]

    Shares of ArQule (NASDAQ:ARQL) rose over 70% today after the company reported full-year 2018 operating results and provided full-year 2019 guidance. That said, investors are probably used to wild swings in the stock price by now. The development-stage pharma didn’t turn in a particularly impressive performance last year. Management expects revenue to drop significantly in the year ahead as collaboration revenue dries up, which will also widen operating losses.

Top 10 Biotech Stocks To Watch Right Now: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Every so often on Rule Breaker Investing, Motley Fool co-founder David Gardner shares a five-stock sampler — five active recommendations in either Rule Breakers or Stock Advisor that are poised for great things. This week: five healthcare companies that are innovating treatments and drugs that are making the world healthier. Learn more about Amgen (NASDAQ:AMGN), bluebird bio (NASDAQ:BLUE), Editas Medicine (NASDAQ:EDIT), Illumina (NASDAQ:ILMN), and Vertex Pharmaceuticals (NASDAQ:VRTX) and why you should add these exciting and inspiring stocks to your watch list.

  • [By ]

    Even though ABBV has more than 100 patents covering Humira, and despite its 2017 patent win over Amgen (Nasdaq: AMGN) requiring AMGN to wait until 2023 before issuing its own copy of Humira, the battle for generic Humira isn’t over.

  • [By Brian Feroldi]

    Amgen (NASDAQ:AMGN) and Biogen (NASDAQ:BIIB) have a lot in common. They are both hugely successful biotech giants that were founded decades ago. They each have produced stellar returns for their long-term shareholders and crank out copious amounts of cash flow each year.

  • [By Cory Renauer]

    A government proposal in the works could lead to important changes that benefit patients and drugmakers, but the industry isn’t going to wait that long. Eli Lilly (NYSE:LLY) recently fired a big arrow at the bulging rebate bubble following signs of success from Amgen (NASDAQ:AMGN) and Gilead Sciences (NASDAQ:GILD). Here’s what you need to know about their effort to change the drug pricing landscape.   

Top 10 Biotech Stocks To Watch Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    Staying on top of every new drugmaker takes a lot more time than you probably have. That said, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Pfizer (NYSE:PFE) shareholders want to keep their eyes on young Eidos and its lead candidate. Here’s why.